Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,9,1.37 [1.16-1.63],0.000286985166873992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KLK10,Kallikrein-10,Inverse variance weighted,7,1.32 [1.1-1.57],0.00229422289689604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KLK6,Kallikrein-6,Inverse variance weighted,3,1.56 [1.14-2.13],0.00551605195003652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,10,1.2 [1.05-1.38],0.00748578155410664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.53 [0.33-0.86],0.00992946468344819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,11,1.18 [1.04-1.35],0.013037648052706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD7,T-cell antigen CD7,Inverse variance weighted,3,0.84 [0.73-0.96],0.013379092011274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HNMT,Histamine N-methyltransferase,Inverse variance weighted,12,0.87 [0.78-0.97],0.013874564490474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,11,1.17 [1.03-1.33],0.0141464167365278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,12,1.27 [1.05-1.54],0.0154738148757899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL7,C-C motif chemokine 7,Inverse variance weighted,2,0.36 [0.14-0.89],0.0265929638474484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ITGA11,Integrin alpha-11,Inverse variance weighted,6,0.77 [0.61-0.97],0.0277160823859842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,10,0.85 [0.73-0.98],0.0279112172191616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SDC4,Syndecan-4,Inverse variance weighted,6,1.85 [1.06-3.23],0.0298228938498032,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.8 [0.66-0.98],0.0319680310057674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KLK14,Kallikrein-14,Inverse variance weighted,11,1.22 [1.01-1.47],0.0354238306763988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,0.42 [0.18-0.95],0.0370400697022938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,2.25 [1.05-4.85],0.0379575716910572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.28 [1.01-1.62],0.0385289267112656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NOTCH3,Neurogenic locus notch homolog protein 3,Wald ratio,1,2.3 [1.04-5.09],0.0391334264245443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.87 [0.76-0.99],0.0398648469453112,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.72 [0.53-0.99],0.0418721852623016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TMSB10,Thymosin beta-10,Wald ratio,1,4.25 [1.04-17.34],0.0437224575490703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,4,0.82 [0.67-1],0.0464866208808365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD83,CD83 antigen,Inverse variance weighted,5,0.74 [0.54-1],0.0472979701602496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,13,0.9 [0.82-1],0.0485083867811022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,6,1.37 [1-1.88],0.049284459697696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,4,0.74 [0.54-1],0.0501069910004072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,4,1.26 [1-1.58],0.0513819894166796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CTSO,Cathepsin O,Inverse variance weighted,7,1.3 [1-1.69],0.0532470427383897,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PCDH1,Protocadherin-1,Wald ratio,1,2.1 [0.99-4.48],0.0546185415426419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,15,1.16 [1-1.35],0.0571419811608594,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LAYN,Layilin,Inverse variance weighted,12,1.19 [0.99-1.42],0.0609363711555223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PRELP,Prolargin,Inverse variance weighted,9,0.86 [0.74-1.01],0.0612271140765829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,12,0.89 [0.78-1.01],0.0614386929970123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,11,0.84 [0.69-1.01],0.0630163350582381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,7,1.46 [0.98-2.17],0.063371769566164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,7,1.1 [0.99-1.23],0.0636923462417904,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD160,CD160 antigen,Inverse variance weighted,5,0.83 [0.69-1.01],0.0659120024172134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,12,0.85 [0.71-1.01],0.0660051525216722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,10,0.84 [0.69-1.01],0.066026082201122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.61 [0.36-1.03],0.0668736632993051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VSTM1,V-set and transmembrane domain-containing protein 1,Inverse variance weighted,9,0.87 [0.75-1.01],0.0677465374368933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,10,1.18 [0.99-1.41],0.0685412511301334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.85 [0.7-1.01],0.0692867909491269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD300E,CMRF35-like molecule 2,Inverse variance weighted,7,0.86 [0.74-1.01],0.0702866197910382,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,12,0.78 [0.6-1.02],0.0704715911101547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,8,0.84 [0.7-1.01],0.0708098625488287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,Inverse variance weighted,5,1.23 [0.98-1.55],0.0708899818459814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.28 [0.07-1.13],0.0737053467013834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,F11R,Junctional adhesion molecule A,Wald ratio,1,0.38 [0.13-1.1],0.0743595691211986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.64 [0.39-1.05],0.076176844689794,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.34 [0.97-1.85],0.0779769751089098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NPY,Pro-neuropeptide Y,Wald ratio,1,3.71 [0.86-16.06],0.0789908041861732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,12,0.89 [0.78-1.01],0.0796213222799084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.75 [0.55-1.03],0.079792873899922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,3,1.77 [0.93-3.4],0.0840943547527996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,7,0.85 [0.71-1.02],0.0844997274741889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,6,0.85 [0.71-1.02],0.0878945027145699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD48,CD48 antigen,Inverse variance weighted,7,1.17 [0.98-1.4],0.0879087717550862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MMP3,Stromelysin-1,Inverse variance weighted,16,1.13 [0.98-1.31],0.0903433099880191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SLAMF8,SLAM family member 8,Inverse variance weighted,14,0.94 [0.88-1.01],0.0913282982729667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,2,2.12 [0.88-5.06],0.0919672853043991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,15,0.87 [0.74-1.02],0.0936529564650836,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,5,1.21 [0.97-1.53],0.0956734426539946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RNASET2,Ribonuclease T2,Inverse variance weighted,9,0.88 [0.75-1.02],0.0964513523329483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ALCAM,CD166 antigen,Inverse variance weighted,4,1.39 [0.93-2.06],0.105050861601268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,8,0.85 [0.69-1.04],0.107796119608702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,13,0.85 [0.69-1.04],0.111541154564444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PRSS2,Trypsin-2,Inverse variance weighted,3,1.36 [0.93-1.99],0.112869155226871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,12,0.88 [0.75-1.03],0.114537851141197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.83 [0.86-3.87],0.115783922036692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,2 [0.84-4.73],0.116198702504137,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,22,0.93 [0.85-1.02],0.116572324513914,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,11,0.88 [0.75-1.03],0.119314274898112,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MATN2,Matrilin-2,Inverse variance weighted,8,0.79 [0.59-1.06],0.120070693412336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PRND,Prion-like protein doppel,Inverse variance weighted,8,1.14 [0.96-1.36],0.124980879266155,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,3,0.55 [0.25-1.18],0.125037638411878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,10,0.91 [0.81-1.03],0.129050363511982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GDF15,Growth/differentiation factor 15,Inverse variance weighted,10,1.17 [0.95-1.43],0.131015238395692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD164,Sialomucin core protein 24,Inverse variance weighted,3,1.34 [0.92-1.96],0.131898981346485,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.27 [0.93-1.73],0.133894104565274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,21,0.9 [0.79-1.03],0.134143134025404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,9,1.14 [0.96-1.34],0.134505643199504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL14,C-C motif chemokine 14,Inverse variance weighted,9,1.22 [0.94-1.58],0.13615314375911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CHGB,Secretogranin-1,Inverse variance weighted,17,0.87 [0.72-1.05],0.137647225945988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,1.56 [0.86-2.81],0.142506197550046,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CSTB,Cystatin-B,Inverse variance weighted,23,1.07 [0.98-1.18],0.142738166104596,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1.31 [0.91-1.88],0.143488891354653,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CTHRC1,Collagen triple helix repeat-containing protein 1,Wald ratio,1,0.29 [0.06-1.53],0.145988571077763,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RBP7,Retinoid-binding protein 7,Inverse variance weighted,4,1.48 [0.87-2.5],0.146483192082169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,19,1.08 [0.97-1.2],0.146956226377737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,21,1.06 [0.98-1.16],0.148449178902834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,8,1.1 [0.97-1.25],0.150647466096933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,1.66 [0.82-3.32],0.156029854963765,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,14,1.07 [0.97-1.18],0.158214656684907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CST3,Cystatin-C,Inverse variance weighted,7,1.17 [0.94-1.47],0.161451521232362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,20,0.93 [0.84-1.03],0.161945278316632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PI3,Elafin,Inverse variance weighted,7,1.11 [0.96-1.29],0.168154104661258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,1.07 [0.97-1.17],0.168773872689552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NPL,N-acetylneuraminate lyase,Inverse variance weighted,4,0.82 [0.62-1.09],0.169079683245649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SIGLEC1,Sialoadhesin,Inverse variance weighted,11,1.09 [0.97-1.22],0.16978435176588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ANG,Angiogenin,Inverse variance weighted,14,1.1 [0.96-1.27],0.171506218629035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,13,1.1 [0.96-1.27],0.173691382853929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,Inverse variance weighted,20,0.94 [0.86-1.03],0.175930952727265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TFRC,Transferrin receptor protein 1,Inverse variance weighted,18,0.9 [0.78-1.05],0.178187864872788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,6,0.88 [0.73-1.06],0.180499503877584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CST5,Cystatin-D,Inverse variance weighted,16,0.91 [0.79-1.05],0.184915582938485,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD55,Complement decay-accelerating factor,Inverse variance weighted,10,0.9 [0.78-1.05],0.18789227850401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,14,1.09 [0.96-1.25],0.192345078606235,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,8,1.12 [0.94-1.34],0.197020426970063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL21,C-C motif chemokine 21,Inverse variance weighted,2,1.6 [0.78-3.27],0.199203224524515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CA9,Carbonic anhydrase 9,Inverse variance weighted,2,1.3 [0.87-1.93],0.201155165178185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.69 [0.39-1.23],0.213636328711658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,10,1.11 [0.94-1.3],0.214022399318537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,12,1.08 [0.96-1.21],0.214150683123966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NECTIN2,Nectin-2,Inverse variance weighted,3,0.82 [0.6-1.12],0.214373305494582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,15,0.93 [0.83-1.04],0.215992630946712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,14,0.9 [0.75-1.07],0.216427599379418,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,8,0.88 [0.73-1.08],0.216679403259214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CTSL,Cathepsin L1,Wald ratio,1,2.25 [0.62-8.22],0.218832230435242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,7,0.78 [0.53-1.16],0.219240190599222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,3,0.73 [0.44-1.21],0.223503768856253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.31 [0.85-2.01],0.224071119793379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,4,1.11 [0.94-1.32],0.224345191903518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,XCL1,Lymphotactin,Inverse variance weighted,15,0.94 [0.85-1.04],0.22469771572804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,12,1.13 [0.93-1.38],0.22751469506422,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CLGN,Calmegin,Inverse variance weighted,14,1.06 [0.96-1.17],0.230844488520418,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PROS1,Vitamin K-dependent protein S,Wald ratio,1,0.44 [0.11-1.71],0.237231285504282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,6,0.91 [0.78-1.06],0.237372203084008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,18,1.06 [0.96-1.18],0.239876282479219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,5,1.25 [0.86-1.82],0.240280438074871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,7,1.11 [0.93-1.32],0.242320965481705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,7,1.1 [0.94-1.29],0.242469329813757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SERPINA11,Serpin A11,Inverse variance weighted,15,1.08 [0.95-1.23],0.243786774400617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,F3,Tissue factor,Inverse variance weighted,7,0.86 [0.68-1.11],0.245898548800688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,1.23 [0.87-1.75],0.246557833134419,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.52 [0.17-1.57],0.246722638796063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.7 [0.69-4.15],0.247176804241942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,5,1.2 [0.88-1.62],0.251733748891192,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SDC1,Syndecan-1,Inverse variance weighted,3,1.25 [0.85-1.84],0.255592159159957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ESAM,Endothelial cell-selective adhesion molecule,Wald ratio,1,1.3 [0.83-2.03],0.255742537473272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,JAM2,Junctional adhesion molecule B,Wald ratio,1,2.21 [0.56-8.72],0.256694769819671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,10,0.9 [0.75-1.08],0.256720687246642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,14,0.93 [0.82-1.06],0.261989579339617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,1.4 [0.78-2.52],0.262768678830443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL5RA,Interleukin-5 receptor subunit alpha,Inverse variance weighted,13,1.08 [0.95-1.22],0.263982844659229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LGALS9,Galectin-9,Inverse variance weighted,12,1.14 [0.91-1.43],0.264832236113239,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,5,0.8 [0.53-1.19],0.267453449783598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,4,1.12 [0.92-1.36],0.267938656659444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,2,1.62 [0.69-3.8],0.268712075471771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,6,0.87 [0.67-1.12],0.269033542068357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Inverse variance weighted,7,1.19 [0.87-1.62],0.272415979487987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.13 [0.91-1.41],0.273605138986519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CPM,Carboxypeptidase M,Inverse variance weighted,3,1.25 [0.84-1.86],0.274594517790109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,3,1.34 [0.79-2.26],0.275605917572943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,4,0.87 [0.68-1.12],0.276382582640892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,3,0.9 [0.74-1.09],0.27679851477265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PALM,Paralemmin-1,Inverse variance weighted,5,1.18 [0.87-1.59],0.282927699207931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,13,1.07 [0.94-1.22],0.290133095623496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD46,Membrane cofactor protein,Wald ratio,1,0.69 [0.34-1.38],0.290510574768535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADA2,Adenosine deaminase 2,Inverse variance weighted,3,0.87 [0.67-1.13],0.29601786009066,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD300A,CMRF35-like molecule 8,Inverse variance weighted,3,1.11 [0.91-1.35],0.296527443373455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,9,1.09 [0.92-1.29],0.302047954570083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NFASC,Neurofascin,Inverse variance weighted,14,0.94 [0.83-1.06],0.302769798927508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,3,1.15 [0.88-1.49],0.303238903975637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,12,1.07 [0.94-1.23],0.30538810341676,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,6,0.9 [0.73-1.1],0.30837326243797,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PRTG,Protogenin,Inverse variance weighted,7,0.92 [0.78-1.08],0.310729965232814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,4,0.88 [0.68-1.13],0.312217272315314,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,6,0.85 [0.62-1.16],0.314683181389545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.75 [0.42-1.32],0.316984727838992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Wald ratio,1,0.77 [0.45-1.3],0.320882505562604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.67 [0.31-1.47],0.321291438597455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EFNA1,Ephrin-A1,Inverse variance weighted,8,1.12 [0.9-1.39],0.322894737793107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CALCA,Calcitonin,Inverse variance weighted,3,1.53 [0.66-3.55],0.325009723582634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,REG1A,Lithostathine-1-alpha,Inverse variance weighted,8,0.91 [0.75-1.1],0.326348294773298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GM2A,Ganglioside GM2 activator,Inverse variance weighted,16,1.07 [0.94-1.21],0.32875736869397,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,11,0.92 [0.78-1.09],0.329233320202016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,3,1.21 [0.82-1.79],0.331298052022595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FABP5,Fatty acid-binding protein 5,Wald ratio,1,0.75 [0.42-1.34],0.332831438820321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,3,0.92 [0.77-1.09],0.333137498355126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,AMBP,Protein AMBP,Inverse variance weighted,3,0.74 [0.41-1.36],0.334394727146973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ULBP2,UL16-binding protein 2,Inverse variance weighted,13,0.93 [0.81-1.07],0.334787548816852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TCN2,Transcobalamin-2,Inverse variance weighted,18,0.95 [0.87-1.05],0.336200567168533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.93 [0.81-1.07],0.336970367559936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1.14 [0.87-1.51],0.338443641380871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.31 [0.75-2.3],0.339807567003191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,INHBB,Inhibin beta B chain,Inverse variance weighted,6,1.08 [0.92-1.27],0.339964992619077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MANSC1,MANSC domain-containing protein 1,Wald ratio,1,0.55 [0.16-1.87],0.342293041566815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RTBDN,Retbindin,Inverse variance weighted,2,1.21 [0.82-1.77],0.344417861169691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CHGA,Chromogranin-A,Inverse variance weighted,3,1.23 [0.8-1.9],0.345362392512978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL16,Pro-interleukin-16,Inverse variance weighted,12,1.07 [0.93-1.22],0.346626113578992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,UMOD,Uromodulin,Inverse variance weighted,18,1.05 [0.95-1.15],0.348111924568824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,11,1.13 [0.87-1.47],0.349353672540992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FCRLB,Fc receptor-like B,Inverse variance weighted,16,1.05 [0.95-1.17],0.349526247618795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RSPO1,R-spondin-1,Inverse variance weighted,4,1.1 [0.9-1.36],0.351941739618123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL20,C-C motif chemokine 20,Wald ratio,1,1.37 [0.71-2.66],0.352711163624442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,14,1.1 [0.9-1.33],0.353526596952539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,2.05 [0.45-9.33],0.354872919577413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CLSTN2,Calsyntenin-2,Inverse variance weighted,15,0.94 [0.82-1.07],0.355732860189465,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Wald ratio,1,0.57 [0.17-1.89],0.359019729425121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,8,0.95 [0.86-1.06],0.359668251896924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,14,1.1 [0.9-1.35],0.360815820016039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.55 [0.61-3.93],0.361116881410097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DKK3,Dickkopf-related protein 3,Inverse variance weighted,8,0.93 [0.8-1.08],0.361684777514988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,BOLA1,BolA-like protein 1,Wald ratio,1,1.31 [0.74-2.32],0.362826378861811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,4,0.91 [0.75-1.11],0.364477178776329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.72 [0.52-5.68],0.37073062121955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,8,0.95 [0.85-1.06],0.372073662421561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,REG1B,Lithostathine-1-beta,Inverse variance weighted,10,0.93 [0.8-1.09],0.372478606945819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,4,1.13 [0.86-1.49],0.373525370788972,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MMP12,Macrophage metalloelastase,Inverse variance weighted,15,0.95 [0.85-1.06],0.377282706952536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,8,0.96 [0.87-1.05],0.377849579927708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD59,CD59 glycoprotein,Inverse variance weighted,5,1.11 [0.88-1.41],0.37964480477052,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,18,1.05 [0.94-1.18],0.380501358074245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,2,1.27 [0.74-2.19],0.383552839792277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,3,0.89 [0.68-1.16],0.385930425745164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,BSG,Basigin,Wald ratio,1,1.21 [0.78-1.88],0.388349937410469,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,14,1.06 [0.93-1.21],0.388391203839518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PPL,Periplakin,Wald ratio,1,0.73 [0.35-1.51],0.393402536635945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,3,1.16 [0.83-1.62],0.393469124779292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,WNT9A,Protein Wnt-9a,Inverse variance weighted,2,0.43 [0.06-3.01],0.394318101379274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.15 [0.84-1.57],0.39666407608012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CTSZ,Cathepsin Z,Wald ratio,1,1.96 [0.41-9.34],0.397060686246857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CDH2,Cadherin-2,Inverse variance weighted,3,1.21 [0.78-1.87],0.398349485745069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,14,1.04 [0.95-1.14],0.399386822595403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,3,1.12 [0.86-1.48],0.400053360568442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DRAXIN,Draxin,Inverse variance weighted,8,1.09 [0.89-1.34],0.403369395948678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,AREG,Amphiregulin,Inverse variance weighted,3,1.24 [0.75-2.07],0.404200028546573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,AGRP,Agouti-related protein,Wald ratio,1,1.9 [0.42-8.63],0.404355420274671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,2,1.79 [0.45-7.07],0.404653995932102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CX3CL1,Fractalkine,Inverse variance weighted,5,0.8 [0.47-1.36],0.40809551484061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,AOC3,Membrane primary amine oxidase,Inverse variance weighted,13,1.05 [0.93-1.19],0.410860639452347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,1.38 [0.64-2.97],0.411316723669047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CALB1,Calbindin,Wald ratio,1,0.61 [0.19-2],0.415757373898645,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,AHNAK2,Protein AHNAK2,Inverse variance weighted,3,1.12 [0.85-1.46],0.416708220257134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.86 [0.59-1.25],0.417099295010677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,4,0.89 [0.66-1.19],0.417550552056981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,8,0.89 [0.66-1.18],0.417975757723018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD27,CD27 antigen,Inverse variance weighted,8,0.92 [0.76-1.12],0.421855638825903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.19 [0.78-1.82],0.424183644339394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.54 [0.53-4.43],0.427644617465708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,2,0.86 [0.59-1.25],0.427868554714462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCG2,Secretogranin-2,Wald ratio,1,0.57 [0.14-2.28],0.42874694303821,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MPO,Myeloperoxidase,Inverse variance weighted,5,1.34 [0.65-2.74],0.429304284278428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCN5,CCN family member 5,Inverse variance weighted,3,1.24 [0.73-2.1],0.432988726319356,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCN4,CCN family member 4,Inverse variance weighted,14,0.96 [0.85-1.07],0.433970260582489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.87 [0.62-1.23],0.436682519918903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD79B,B-cell antigen receptor complex-associated protein beta chain,Wald ratio,1,0.86 [0.59-1.26],0.437496811540892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.21 [0.74-1.98],0.437752124083976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,THBD,Thrombomodulin,Inverse variance weighted,5,1.13 [0.83-1.55],0.438527107796788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TFF3,Trefoil factor 3,Inverse variance weighted,3,1.22 [0.73-2.03],0.443665976369264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD302,CD302 antigen,Inverse variance weighted,6,1.08 [0.89-1.31],0.445165905007971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.37 [0.61-3.07],0.446575961320431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.18 [0.77-1.83],0.447066146420531,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LCN15,Lipocalin-15,Inverse variance weighted,6,0.95 [0.82-1.09],0.448285845887636,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,11,0.93 [0.77-1.12],0.450699070862873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,10,1.07 [0.9-1.28],0.451947446603971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,9,1.08 [0.89-1.31],0.453025583152757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,24,1.04 [0.94-1.15],0.454434903594023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,3,1.27 [0.67-2.4],0.454983417823224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.29 [0.66-2.49],0.455614780529322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DBI,Acyl-CoA-binding protein,Inverse variance weighted,7,1.08 [0.89-1.3],0.456340720023394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPARCL1,SPARC-like protein 1,Inverse variance weighted,15,1.04 [0.94-1.16],0.458068363477225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,6,0.91 [0.71-1.17],0.470118255441124,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.2 [0.72-2],0.472762890878667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,1.22 [0.7-2.13],0.472762890878667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.24 [0.68-2.26],0.474924731566525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,1.2 [0.73-1.97],0.477085950715506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,2,0.85 [0.55-1.32],0.477117686340207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,3,0.92 [0.73-1.16],0.477532135232081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,3,0.91 [0.7-1.19],0.479895772891382,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,20,0.97 [0.88-1.06],0.480587614507607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MDK,Midkine,Inverse variance weighted,3,1.2 [0.73-1.98],0.481154096010906,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SHISA5,Protein shisa-5,Inverse variance weighted,3,0.82 [0.46-1.44],0.486070904739252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,0.91 [0.71-1.18],0.487189138830608,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,4,1.15 [0.77-1.74],0.490050146229746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,20,0.97 [0.88-1.06],0.490369235651001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CAPG,Macrophage-capping protein,Inverse variance weighted,15,1.05 [0.92-1.18],0.490422043340651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,9,1.05 [0.92-1.2],0.491400989663048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.93 [0.76-1.14],0.492242977386417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,15,1.05 [0.91-1.21],0.493249805960993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,6,1.17 [0.75-1.81],0.494563930743803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,1.28 [0.63-2.6],0.501224458514579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,16,0.95 [0.83-1.09],0.50128711952474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,7,1.08 [0.87-1.33],0.502348125070338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.72 [0.27-1.9],0.504638994569461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,4,1.16 [0.75-1.79],0.505004990833992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,3,0.95 [0.81-1.11],0.506066597694822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NOS3,"Nitric oxide synthase, endothelial",Wald ratio,1,0.64 [0.18-2.36],0.508184442839974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PLXNB2,Plexin-B2,Inverse variance weighted,13,0.97 [0.9-1.05],0.508902684568653,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,3,1.22 [0.67-2.25],0.513640945193865,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GUCA2A,Guanylin,Inverse variance weighted,4,0.91 [0.69-1.2],0.514125054943978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RETN,Resistin,Inverse variance weighted,4,1.08 [0.85-1.37],0.516145221298984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPON1,Spondin-1,Inverse variance weighted,10,0.94 [0.79-1.13],0.517227917880604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PRTN3,Myeloblastin,Inverse variance weighted,8,0.9 [0.66-1.23],0.518313744082625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,14,1.06 [0.89-1.25],0.520003860780708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.23 [0.65-2.34],0.521582218223759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.12 [0.79-1.6],0.522100917797188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CFD,Complement factor D,Inverse variance weighted,7,1.11 [0.8-1.54],0.523638392598827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,5,1.08 [0.85-1.37],0.524277917314104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.13 [0.77-1.66],0.526733033459755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DSC2,Desmocollin-2,Inverse variance weighted,4,1.08 [0.86-1.36],0.527952591020608,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.38 [0.5-3.8],0.528130032688705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,4,1.09 [0.83-1.44],0.528739933359852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,4,1.31 [0.56-3.06],0.52958071849296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CALB2,Calretinin,Wald ratio,1,0.73 [0.27-1.96],0.530248461270502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,6,0.95 [0.82-1.11],0.531335018555554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CTSD,Cathepsin D,Inverse variance weighted,7,0.93 [0.75-1.16],0.533234581408661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,2,0.84 [0.48-1.46],0.533900999823641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCGB3A1,Secretoglobin family 3A member 1,Inverse variance weighted,2,1.35 [0.52-3.47],0.533922284834114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,5,0.91 [0.68-1.22],0.534452197061969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SLC39A5,Zinc transporter ZIP5,Wald ratio,1,1.37 [0.51-3.71],0.53455724949283,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,10,0.92 [0.7-1.2],0.535849283919463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCG3,Secretogranin-3,Inverse variance weighted,22,0.97 [0.87-1.07],0.536589258873857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL22,C-C motif chemokine 22,Inverse variance weighted,4,1.11 [0.79-1.56],0.536828226168494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CLMP,CXADR-like membrane protein,Inverse variance weighted,9,0.95 [0.8-1.12],0.53736346986607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,8,0.93 [0.73-1.18],0.537674298939493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD300C,CMRF35-like molecule 6,Wald ratio,1,0.88 [0.58-1.33],0.538095388778816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,5,1.1 [0.81-1.49],0.540046961959602,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,11,1.05 [0.9-1.23],0.540049613053168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL18,C-C motif chemokine 18,Inverse variance weighted,5,0.87 [0.57-1.34],0.540355226118062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PSAP,Prosaposin,Inverse variance weighted,4,1.09 [0.83-1.42],0.541734423421054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NECTIN4,Nectin-4,Inverse variance weighted,6,0.94 [0.78-1.14],0.544105368846367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,6,1.25 [0.61-2.56],0.545159534639947,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NPPB,Natriuretic peptides B,Wald ratio,1,0.9 [0.64-1.27],0.545527307032394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.89 [0.61-1.3],0.546162062064143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PCDHB15,Protocadherin beta-15,Inverse variance weighted,15,1.03 [0.93-1.15],0.549011799847924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PTPRR,Receptor-type tyrosine-protein phosphatase R,Wald ratio,1,0.63 [0.14-2.85],0.549563364373056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,8,1.13 [0.76-1.66],0.550208681365413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL17C,Interleukin-17C,Inverse variance weighted,3,1.15 [0.73-1.8],0.552423915271135,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MMP10,Stromelysin-2,Inverse variance weighted,10,0.96 [0.84-1.09],0.552835232051369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,7,0.94 [0.78-1.14],0.552984264347806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,4,0.93 [0.72-1.19],0.555222848853554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NCS1,Neuronal calcium sensor 1,Wald ratio,1,0.86 [0.51-1.43],0.555397309392828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,7,1.14 [0.74-1.75],0.556349565045983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FGF5,Fibroblast growth factor 5,Inverse variance weighted,17,0.96 [0.85-1.09],0.557073961960846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,2,0.88 [0.58-1.34],0.558067755118903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,12,1.04 [0.9-1.2],0.561496431938626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.7 [0.2-2.4],0.564695220177785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,1.36 [0.47-3.93],0.565388064281764,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,4,0.78 [0.33-1.84],0.56769373889437,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,6,0.94 [0.74-1.18],0.569039941968783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,15,1.05 [0.88-1.25],0.57141545682323,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL18,Interleukin-18,Inverse variance weighted,9,0.87 [0.54-1.4],0.571966661511208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,5,1.08 [0.83-1.41],0.572251243725239,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,8,0.97 [0.88-1.07],0.572618024497271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NRP1,Neuropilin-1,Inverse variance weighted,8,1.05 [0.88-1.26],0.575391577861993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FOLR2,Folate receptor beta,Wald ratio,1,1.18 [0.67-2.08],0.575889403429379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,12,1.05 [0.89-1.24],0.576146468161873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,5,1.13 [0.73-1.76],0.578514572197985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,7,1.06 [0.85-1.33],0.584386996284645,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LGALS1,Galectin-1,Inverse variance weighted,4,0.93 [0.71-1.21],0.584819831154219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,17,1.03 [0.94-1.12],0.586742795779809,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Wald ratio,1,1.5 [0.34-6.6],0.588052799611197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,7,1.08 [0.81-1.45],0.590293034063624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.86 [0.49-1.5],0.591830814052149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,2,0.71 [0.2-2.48],0.59268082601735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,WFDC2,WAP four-disulfide core domain protein 2,Wald ratio,1,1.25 [0.56-2.8],0.593887279778756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,4,1.14 [0.7-1.87],0.594871712138675,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,Inverse variance weighted,15,1.05 [0.88-1.26],0.594963328582321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL25,C-C motif chemokine 25,Inverse variance weighted,20,1.03 [0.92-1.16],0.598052678953886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,6,0.94 [0.76-1.17],0.598612417447907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DSG2,Desmoglein-2,Inverse variance weighted,6,1.07 [0.83-1.37],0.599056811096454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,F10,Coagulation factor X,Inverse variance weighted,3,0.9 [0.61-1.33],0.600387010905889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,C7,Complement component C7,Inverse variance weighted,15,1.03 [0.93-1.14],0.601090106816447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.83 [0.41-1.67],0.601325743975205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CDH3,Cadherin-3,Wald ratio,1,0.81 [0.36-1.81],0.601837039690736,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,6,1.06 [0.86-1.3],0.606049022547424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PYY,Peptide YY,Inverse variance weighted,3,0.93 [0.72-1.21],0.60766839285624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,1.58 [0.27-9.28],0.609771456252241,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,19,1.02 [0.95-1.1],0.610237305496497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CA4,Carbonic anhydrase 4,Inverse variance weighted,3,1.05 [0.87-1.26],0.611522673662278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VWC2,Brorin,Inverse variance weighted,15,1.04 [0.89-1.21],0.614662641191259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,5,1.13 [0.71-1.8],0.61767274794376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VGF,Neurosecretory protein VGF,Wald ratio,1,0.72 [0.19-2.69],0.622344392829395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,3,1.11 [0.73-1.69],0.623855456709849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,8,1.07 [0.81-1.41],0.624228043214911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KLK11,Kallikrein-11,Inverse variance weighted,2,1.04 [0.89-1.23],0.624881427194407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,13,0.95 [0.75-1.19],0.625403398309633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PLIN3,Perilipin-3,Wald ratio,1,0.78 [0.29-2.09],0.627495243089182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PENK,Proenkephalin-A,Inverse variance weighted,11,0.96 [0.81-1.13],0.628776409698503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DLL1,Delta-like protein 1,Inverse variance weighted,3,1.09 [0.76-1.57],0.629431834930781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PVR,Poliovirus receptor,Inverse variance weighted,13,0.98 [0.88-1.08],0.632277318145286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,2,0.78 [0.28-2.18],0.63461209777997,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MFGE8,Lactadherin,Inverse variance weighted,7,0.92 [0.66-1.29],0.634680257094286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,5,1.05 [0.85-1.29],0.639638473434856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PKD1,Polycystin-1,Inverse variance weighted,5,1.08 [0.79-1.47],0.641094109584283,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FGF23,Fibroblast growth factor 23,Wald ratio,1,1.15 [0.64-2.07],0.643643445141774,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,3,1.29 [0.44-3.79],0.646378484115619,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.14 [0.66-1.96],0.6465152334758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SNCG,Gamma-synuclein,Inverse variance weighted,13,0.97 [0.87-1.09],0.64709305527542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KLK8,Kallikrein-8,Inverse variance weighted,7,1.05 [0.86-1.28],0.647784317726883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,7,0.96 [0.79-1.16],0.649595173712497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,10,0.96 [0.82-1.13],0.6509433982447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,5,1.05 [0.84-1.33],0.65233668216618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ARHGEF5,Rho guanine nucleotide exchange factor 5,Inverse variance weighted,13,0.97 [0.86-1.1],0.653065270973346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.84 [0.38-1.83],0.654383875638831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,7,0.94 [0.72-1.23],0.654628533776404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MSLN,Mesothelin,Inverse variance weighted,14,1.05 [0.84-1.31],0.654642886859352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TFF1,Trefoil factor 1,Inverse variance weighted,7,0.95 [0.76-1.19],0.656427544873745,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,3,1.07 [0.8-1.43],0.656438227928409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,8,0.97 [0.84-1.11],0.658019505269533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CA6,Carbonic anhydrase 6,Inverse variance weighted,17,1.03 [0.91-1.17],0.659412545676727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL19,Interleukin-19,Inverse variance weighted,7,1.05 [0.86-1.28],0.659663527767171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,15,0.96 [0.81-1.14],0.659767156957728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,5,0.92 [0.64-1.32],0.661501448276978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.83 [0.36-1.93],0.665089178811623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FBLN2,Fibulin-2,Inverse variance weighted,3,0.93 [0.67-1.3],0.666598334890309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TFF2,Trefoil factor 2,Inverse variance weighted,3,1.09 [0.73-1.64],0.669136676721227,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.21 [0.5-2.89],0.670746734737751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,15,0.97 [0.84-1.12],0.670949628980965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,3,1.05 [0.85-1.29],0.672843549501862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,9,0.96 [0.79-1.16],0.674407021024529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,2,1.1 [0.71-1.69],0.67961779028704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,5,0.95 [0.76-1.2],0.685497851851611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,1.09 [0.73-1.62],0.686479159288328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,AGRN,Agrin,Inverse variance weighted,6,0.95 [0.75-1.2],0.686599001308694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MILR1,Allergin-1,Inverse variance weighted,20,0.98 [0.87-1.09],0.688583443573679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KLK4,Kallikrein-4,Inverse variance weighted,8,0.96 [0.8-1.16],0.688748717291051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,4,1.05 [0.84-1.3],0.691085651876984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL15,C-C motif chemokine 15,Inverse variance weighted,11,1.02 [0.92-1.13],0.69312044838454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.16 [0.55-2.44],0.693639129204148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EGFLAM,Pikachurin,Inverse variance weighted,12,0.98 [0.89-1.08],0.696962798432497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.96 [0.79-1.17],0.69840939757092,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EPO,Erythropoietin,Wald ratio,1,1.17 [0.52-2.63],0.700154529511362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SEZ6L,Seizure 6-like protein,Inverse variance weighted,7,0.91 [0.57-1.46],0.701131321145552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RGMB,RGM domain family member B,Inverse variance weighted,6,0.94 [0.69-1.28],0.701214691864707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,COLEC12,Collectin-12,Inverse variance weighted,7,0.94 [0.68-1.3],0.701953629813299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,5,1.06 [0.77-1.47],0.702352587583758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL23,C-C motif chemokine 23,Inverse variance weighted,12,0.98 [0.86-1.11],0.704084287719432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HJV,Hemojuvelin,Wald ratio,1,1.08 [0.72-1.63],0.705655163498159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GPR15L,Protein GPR15L,Inverse variance weighted,6,1.06 [0.79-1.42],0.707781643172285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,6,1.04 [0.84-1.28],0.708444022748663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PODXL2,Podocalyxin-like protein 2,Wald ratio,1,0.93 [0.63-1.37],0.708713823962061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SLC39A14,Zinc transporter ZIP14,Wald ratio,1,0.88 [0.46-1.69],0.710920887407396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,1.11 [0.64-1.92],0.71740683698952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,2,0.87 [0.41-1.85],0.720060913821416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PTN,Pleiotrophin,Inverse variance weighted,3,1.21 [0.43-3.35],0.720190856521942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.09 [0.68-1.74],0.720242457563864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,11,0.98 [0.86-1.11],0.720259242982195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.93 [0.64-1.36],0.723316519449334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.94 [0.66-1.33],0.723759303860165,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,6,0.98 [0.85-1.12],0.723974675051946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PRRT3,Proline-rich transmembrane protein 3,Wald ratio,1,0.91 [0.55-1.52],0.724875811636121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CTSV,Cathepsin L2,Inverse variance weighted,2,0.79 [0.22-2.92],0.726323491624912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.93 [0.62-1.4],0.727147571297932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.19 [0.44-3.26],0.731331682977032,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PCDH17,Protocadherin-17,Inverse variance weighted,2,1.13 [0.55-2.34],0.73314388366242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MB,Myoglobin,Wald ratio,1,1.33 [0.25-7.11],0.735088265036168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ANXA10,Annexin A10,Wald ratio,1,0.81 [0.24-2.75],0.737474156672535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HYAL1,Hyaluronidase-1,Inverse variance weighted,4,1.05 [0.81-1.36],0.739553594327108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PALM2,Paralemmin-2,Inverse variance weighted,8,1.05 [0.78-1.42],0.739918952810555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Wald ratio,1,0.89 [0.44-1.81],0.740375956285801,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,3,1.09 [0.65-1.81],0.743187144830862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NRP2,Neuropilin-2,Inverse variance weighted,10,1.05 [0.77-1.45],0.743261834800598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RSPO3,R-spondin-3,Inverse variance weighted,3,1.06 [0.75-1.49],0.746825056047751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.89 [0.42-1.85],0.746865231052563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CSPG4,Chondroitin sulfate proteoglycan 4,Wald ratio,1,1.09 [0.65-1.84],0.747276529247421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,10,1.04 [0.82-1.32],0.750257805465485,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CST6,Cystatin-M,Wald ratio,1,0.95 [0.69-1.3],0.750563229108978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,4,0.97 [0.79-1.19],0.752297480983132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,18,1.02 [0.92-1.12],0.752964635052223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FAM3B,Protein FAM3B,Inverse variance weighted,8,1.02 [0.91-1.15],0.754038162305404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,4,1.04 [0.8-1.36],0.754475855792562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,4,0.94 [0.66-1.35],0.75700121429782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,10,0.98 [0.85-1.13],0.759234263265368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.11 [0.56-2.2],0.759771574821538,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EDN1,Endothelin-1,Inverse variance weighted,3,0.96 [0.75-1.24],0.765068172030444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CTSB,Cathepsin B,Inverse variance weighted,13,1.03 [0.83-1.29],0.765412225380042,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,3,0.95 [0.7-1.3],0.766819356363037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MMP13,Collagenase 3,Wald ratio,1,1.22 [0.33-4.58],0.768194549274899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,APOA2,Apolipoprotein A-II,Wald ratio,1,1.15 [0.45-2.92],0.770001733307262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,3,1.05 [0.77-1.42],0.770146449314181,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,13,0.99 [0.89-1.09],0.771409593011835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,OGFR,Opioid growth factor receptor,Wald ratio,1,1.12 [0.51-2.45],0.7723514159076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LUZP2,Leucine zipper protein 2,Inverse variance weighted,7,1.03 [0.84-1.27],0.772692034509161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PRSS8,Prostasin,Inverse variance weighted,4,0.92 [0.54-1.59],0.772798086517057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.11 [0.52-2.37],0.779002106063223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPP1,Osteopontin,Inverse variance weighted,7,0.94 [0.63-1.42],0.780113965668878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,1.09 [0.59-2.03],0.782329865345987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,16,1.01 [0.93-1.1],0.787050160913863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,Wald ratio,1,1.07 [0.64-1.8],0.788767474941664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD276,CD276 antigen,Inverse variance weighted,14,0.98 [0.87-1.11],0.791747904387071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,5,0.95 [0.66-1.37],0.792889837704523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,2,0.94 [0.61-1.46],0.794766345099257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,12,1.02 [0.89-1.17],0.795265622413391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EFNA4,Ephrin-A4,Wald ratio,1,0.85 [0.25-2.88],0.796480060090525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RBP2,Retinol-binding protein 2,Wald ratio,1,0.89 [0.35-2.22],0.797585251294506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,21,0.99 [0.88-1.1],0.799141885923281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,18,0.99 [0.88-1.1],0.799908032331831,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,1.02 [0.88-1.18],0.800001348404211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.92 [0.49-1.74],0.805377343224584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,7,1.02 [0.86-1.22],0.807153388421994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,4,1.04 [0.76-1.43],0.807603690167713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IGLC2,Immunoglobulin lambda constant 2,Wald ratio,1,1.09 [0.53-2.27],0.808338719105849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CTSS,Cathepsin S,Inverse variance weighted,14,0.98 [0.85-1.13],0.809012435147853,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,Inverse variance weighted,7,0.97 [0.78-1.22],0.814517417763999,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,3,1.02 [0.84-1.25],0.817039073528512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,10,0.98 [0.86-1.13],0.817255483245968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RNASE6,Ribonuclease K6,Inverse variance weighted,8,1.01 [0.9-1.15],0.817391857223139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCN3,CCN family member 3,Inverse variance weighted,13,1.02 [0.85-1.23],0.818142796782655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.94 [0.55-1.59],0.818860710765094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,5,1.02 [0.86-1.2],0.81980051354252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DPT,Dermatopontin,Inverse variance weighted,16,0.98 [0.81-1.18],0.821729670385158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ELN,Elastin,Wald ratio,1,0.92 [0.44-1.91],0.827179857751508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,8,1.03 [0.81-1.3],0.827891045573512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,OGN,Mimecan,Inverse variance weighted,24,1.01 [0.9-1.13],0.828043881151544,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.13 [0.36-3.54],0.829829474447231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,2,0.96 [0.68-1.36],0.832629601096812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,4,0.96 [0.65-1.42],0.835328294326694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,6,1.02 [0.83-1.26],0.835894726126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,3,0.95 [0.57-1.58],0.840148545134722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,2,1.06 [0.61-1.83],0.841063368834272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,5,1.02 [0.83-1.26],0.841142942975174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,3,1.04 [0.7-1.55],0.842115398040316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PGF,Placenta growth factor,Inverse variance weighted,2,1.11 [0.39-3.15],0.842334288067684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.97 [0.75-1.26],0.842500403314684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,12,0.98 [0.81-1.18],0.842523079942558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,6,0.97 [0.71-1.33],0.84565046283699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CXCL10,C-X-C motif chemokine 10,Wald ratio,1,1.09 [0.45-2.66],0.845980200998528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,21,0.99 [0.92-1.07],0.846052648981295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.96 [0.61-1.49],0.846118714672477,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADM,Pro-adrenomedullin,Wald ratio,1,0.94 [0.51-1.74],0.849495258833438,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MMP8,Neutrophil collagenase,Inverse variance weighted,11,1.01 [0.88-1.16],0.853218243220264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.95 [0.54-1.68],0.85323442791475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,6,0.99 [0.88-1.12],0.853884397736352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,16,1.01 [0.87-1.19],0.85496061198188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,7,0.99 [0.87-1.12],0.856560102894098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,BCAM,Basal cell adhesion molecule,Inverse variance weighted,7,1.02 [0.84-1.24],0.859417014687368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,S100P,Protein S100-P,Wald ratio,1,0.91 [0.3-2.73],0.859617439169548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,5,1.03 [0.76-1.38],0.859844822490851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL16,C-C motif chemokine 16,Inverse variance weighted,10,1.01 [0.9-1.14],0.859940262844803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,5,0.97 [0.7-1.34],0.860654936281337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VWF,von Willebrand factor,Inverse variance weighted,2,0.95 [0.56-1.62],0.861731934468582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,2,0.96 [0.59-1.55],0.863633731908272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.08 [0.44-2.64],0.863877968324746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,STC2,Stanniocalcin-2,Inverse variance weighted,2,0.92 [0.38-2.27],0.864890334980518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PKD2,Polycystin-2,Inverse variance weighted,3,1.06 [0.56-2],0.865034726873885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FAM3D,Protein FAM3D,Inverse variance weighted,8,0.96 [0.58-1.58],0.866017118167732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SEMA3F,Semaphorin-3F,Inverse variance weighted,3,1.05 [0.58-1.91],0.867873740323692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,6,1.02 [0.82-1.26],0.868713505813313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,8,0.97 [0.69-1.37],0.87051771157458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GRN,Progranulin,Inverse variance weighted,4,0.98 [0.76-1.27],0.871145965778435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,4,0.97 [0.64-1.45],0.87141815931374,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SEMA7A,Semaphorin-7A,Inverse variance weighted,4,1.06 [0.52-2.15],0.871899605885143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.9 [0.24-3.42],0.872521850356577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,2,0.96 [0.58-1.6],0.873271219356737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LAMB1,Laminin subunit beta-1,Inverse variance weighted,22,1.01 [0.9-1.13],0.874713415355822,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SERPINB8,Serpin B8,Inverse variance weighted,14,0.99 [0.93-1.07],0.874830868979375,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,4,1.05 [0.58-1.9],0.875301344076557,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MUC13,Mucin-13,Inverse variance weighted,9,1.02 [0.82-1.27],0.875739995513019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,3,1.04 [0.65-1.65],0.878350006120526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.02 [0.79-1.32],0.878907347699997,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NPPC,C-type natriuretic peptide,Wald ratio,1,1.12 [0.25-4.92],0.883459901105139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,5,0.98 [0.73-1.31],0.886114440247358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.91 [0.24-3.42],0.886433682313677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD5L,CD5 antigen-like,Inverse variance weighted,5,0.98 [0.7-1.36],0.887122294465626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FGA,Fibrinogen alpha chain,Inverse variance weighted,2,0.97 [0.62-1.52],0.887265211959562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.09 [0.32-3.76],0.888341159384795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,BTN3A2,Butyrophilin subfamily 3 member A2,Wald ratio,1,1.01 [0.85-1.21],0.888545148616358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,12,1.01 [0.85-1.21],0.888629655725716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,8,0.99 [0.85-1.15],0.88912279581591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ENAH,Protein enabled homolog,Inverse variance weighted,2,1.05 [0.55-1.98],0.889959742280466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.99 [0.8-1.22],0.890645243213423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,0.91 [0.22-3.71],0.893086594381129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,12,1.01 [0.84-1.22],0.894250237844833,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,6,0.99 [0.81-1.2],0.895345619074807,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,7,0.99 [0.82-1.19],0.898439353533503,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,7,1.02 [0.73-1.44],0.899726595936689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MMP7,Matrilysin,Inverse variance weighted,9,0.99 [0.81-1.21],0.900956232851464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PDCD1,Programmed cell death protein 1,Inverse variance weighted,2,1.03 [0.67-1.59],0.901552667090526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,13,0.99 [0.87-1.13],0.903129657016524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,13,1.01 [0.88-1.16],0.904363652493792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,2,1.02 [0.73-1.43],0.904418947022778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNC,Tenascin,Inverse variance weighted,7,0.98 [0.73-1.32],0.907541026290624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,4,0.98 [0.65-1.47],0.909885117033388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,7,1.02 [0.71-1.46],0.910072576559464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LGALS4,Galectin-4,Inverse variance weighted,3,1.03 [0.64-1.64],0.910686948064663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FGF21,Fibroblast growth factor 21,Wald ratio,1,1.07 [0.33-3.46],0.912487871874004,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,5,1.01 [0.78-1.32],0.912922238437608,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,10,0.99 [0.86-1.14],0.91483731822347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPON2,Spondin-2,Inverse variance weighted,4,1.01 [0.78-1.32],0.916911130965532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.09 [0.22-5.42],0.917292222460236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,9,1.01 [0.8-1.29],0.92170302501412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CLEC3B,Tetranectin,Inverse variance weighted,6,1.02 [0.73-1.41],0.922341932145517,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,9,0.99 [0.8-1.23],0.922958963506944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CCL3,C-C motif chemokine 3,Inverse variance weighted,6,0.99 [0.82-1.19],0.925248088617455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.04 [0.43-2.55],0.92690065644827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DKK4,Dickkopf-related protein 4,Inverse variance weighted,3,0.98 [0.68-1.42],0.931532369147476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CDH6,Cadherin-6,Inverse variance weighted,16,1 [0.91-1.1],0.935918116988728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,3,1.01 [0.86-1.18],0.936461985160161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,10,1.01 [0.86-1.17],0.938449237137735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCGB1A1,Uteroglobin,Inverse variance weighted,5,1.01 [0.81-1.26],0.939320629058979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,10,0.99 [0.84-1.18],0.948650949174942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,THBS2,Thrombospondin-2,Inverse variance weighted,12,1 [0.86-1.15],0.949845024156941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ITGA5,Integrin alpha-5,Wald ratio,1,0.96 [0.28-3.37],0.955377838418004,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.01 [0.65-1.58],0.955454629569623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,6,1 [0.84-1.18],0.957989224934362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,8,1.01 [0.77-1.32],0.960049922542962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,4,0.99 [0.76-1.29],0.962608991076222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NUCB2,Nucleobindin-2,Inverse variance weighted,13,1 [0.86-1.17],0.963416697051899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,14,1 [0.89-1.13],0.964347250928323,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,32,1 [0.93-1.08],0.965095143006441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,5,1 [0.85-1.17],0.965247479086881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,MSMB,Beta-microseminoprotein,Inverse variance weighted,31,1 [0.91-1.1],0.966111094493473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,REN,Renin,Inverse variance weighted,3,0.99 [0.49-1.97],0.966207640489139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,RNASE4,Ribonuclease 4,Inverse variance weighted,8,1 [0.79-1.26],0.966776015590436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,PGA4,Pepsin A-4,Inverse variance weighted,2,1.02 [0.38-2.74],0.966851631364383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,NXPH3,Neurexophilin-3,Inverse variance weighted,7,1.01 [0.74-1.37],0.968777098301812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,FOLR1,Folate receptor alpha,Inverse variance weighted,3,1.01 [0.64-1.59],0.969040015726439,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,13,1 [0.86-1.16],0.971627525286819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,F2R,Proteinase-activated receptor 1,Inverse variance weighted,2,1.01 [0.62-1.63],0.973038535527941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,8,1 [0.83-1.2],0.974023178128864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,0.98 [0.26-3.71],0.975200845964193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.02 [0.38-2.72],0.976039975067119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.01 [0.52-1.97],0.977037144208974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,OCLN,Occludin,Wald ratio,1,1.01 [0.65-1.56],0.978872476949765,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,7,0.99 [0.63-1.57],0.979341059683155,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VAMP5,Vesicle-associated membrane protein 5,Inverse variance weighted,2,0.99 [0.51-1.91],0.979501868692589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,DTNB,Dystrobrevin beta,Wald ratio,1,1.02 [0.24-4.25],0.980600027338569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,6,1 [0.74-1.33],0.980919242537383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,12,1 [0.9-1.11],0.982181629406366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1 [0.85-1.18],0.982381099186686,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,2,1 [0.69-1.44],0.983336909601767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,13,1 [0.84-1.19],0.98388982080516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SLAMF7,SLAM family member 7,Inverse variance weighted,12,1 [0.89-1.12],0.986203473113859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,5,1 [0.8-1.25],0.987135662965813,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,3,1.01 [0.3-3.41],0.987399745792451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LGALS3,Galectin-3,Inverse variance weighted,14,1 [0.86-1.16],0.988194250415773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,VCAN,Versican core protein,Inverse variance weighted,9,1 [0.84-1.2],0.993914150703715,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,2,1 [0.49-2.04],0.994886742509345,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,10,1 [0.88-1.13],0.99528794030036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,2,1 [0.46-2.15],0.995625035217955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,8,1 [0.87-1.15],0.996655268955848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,ANXA5,Annexin A5,Wald ratio,1,1 [0.57-1.77],0.999202984913878,cis
